Haleon HLN
NYSE HLN
$9.90 +0.03 (+0.25%)
At close: Aug 20, 2026 · 12:47 PM UTC

Haleon (HLN) Non-Current Debt (2021 - 2026)

Haleon's (HLN) quarterly Non-Current Debt came in at -$8.4 billion in Q2 2026, up 18.97% on a QoQ basis from -$10.4 billion in Q4 2025.

Haleon (HLN) Non-Current Debt (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Non-Current Debt data on file, last reported at -$8.4 billion in Q2 2026.

  • Quarterly Non-Current Debt changed N/A year-over-year to -$8.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$8.4 billion (changed N/A YoY) and the FY2025 annual result came in at -$10.3 billion, down 193.62% from the prior year.
  • Non-Current Debt advanced to -$8.4 billion in Q2 2026, from -$10.4 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $11.7 billion in Q4 2022 to a low of -$12.5 billion in Q2 2022.
  • A 5-year average of -$2.2 billion and a median of -$8.9 billion in 2024 frame the typical range for Non-Current Debt.
  • Annual changes were most pronounced in 2022 — Non-Current Debt surged 9904.36% — and 2025, when it slumped 193.91%.
  • Tracing HLN's Non-Current Debt over 5 years: stood at $11.7 billion in 2022, then dropped by 6.91% to $10.9 billion in 2023, then climbed by 1.53% to $11.1 billion in 2024, then tumbled by 193.91% to -$10.4 billion in 2025, then grew by 18.97% to -$8.4 billion in 2026.
  • The last three Non-Current Debt figures came in at -$8.4 billion (Q2 2026), -$10.4 billion (Q4 2025), and $11.1 billion (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -8.44 Bn
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 12.09 Bn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn 9.05 Bn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn 27.73 Bn
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 11.61 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 3.85 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 130.00 Mn
10 Alkermes 8.15 Bn 7.49 Bn 397.90 Mn 1.48 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.44 Bn
Dec 31, 2025 -10.41 Bn
Dec 31, 2024 11.09 Bn
Jun 30, 2024 -9.35 Bn
Dec 31, 2023 10.92 Bn
Jun 30, 2023 -10.97 Bn
Dec 31, 2022 11.73 Bn
Jun 30, 2022 -12.49 Bn
Dec 31, 2021 117.28 Mn